Liver Cancer Screening Blood Test | MoleculeDx, Inc. Explore MoleculeDx, Inc. liver cancer screening blood test research, analyzing cancer-associated fusion-transcript signals through a multi-marker molecular approach. Peer-reviewed HCC studies have evaluated circulating cell-free fusion transcripts and machine-learning models to support liver cancer risk assessment research. For more visit - https://www.moleculedx.com/blood-test-for-liver-cancer/